Bafna Pharmaceuticals Limited
BAFNAPH
Quarterly results
standaloneRevenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Jun 202627
Quarter ₹ crore YoY Jun 2024 33 -20.6% Sept 2024 40 -0.9% Dec 2024 33 +16.7% Mar 2025 39 -5.6% Jun 2025 35 +4.0% Sept 2025 35 -12.0% Dec 2025 38 +15.4% Mar 2026 42 +8.1% Jun 2026 27 -23.2% - ₹ crore
Jun 20262
Quarter ₹ crore Jun 2024 0.51 Sept 2024 1 Dec 2024 0.19 Mar 2025 1 Jun 2025 0.60 Sept 2025 1 Dec 2025 1 Mar 2026 2 Jun 2026 2 - ₹ crore
Jun 202628
Quarter ₹ crore Jun 2024 34 Sept 2024 41 Dec 2024 33 Mar 2025 40 Jun 2025 35 Sept 2025 37 Dec 2025 40 Mar 2026 44 Jun 2026 28 - Cost structure
- ₹ crore
Jun 20266
Quarter ₹ crore Jun 2024 5 Sept 2024 5 Dec 2024 5 Mar 2025 6 Jun 2025 6 Sept 2025 5 Dec 2025 5 Mar 2026 5 Jun 2026 6 - ₹ crore
Jun 202628
Quarter ₹ crore Jun 2024 34 Sept 2024 39 Dec 2024 32 Mar 2025 37 Jun 2025 32 Sept 2025 34 Dec 2025 38 Mar 2026 41 Jun 2026 28 - Exceptional items and tax
- ₹ crore
Jun 20260.08
Quarter ₹ crore Jun 2024 -0.72 Sept 2024 3 Dec 2024 0.95 Mar 2025 1 Jun 2025 3 Sept 2025 3 Dec 2025 2 Mar 2026 3 Jun 2026 0.08 - ₹ crore
Jun 20260
Quarter ₹ crore Jun 2024 0 Sept 2024 0 Dec 2024 0 Mar 2025 0 Jun 2025 0 Sept 2025 0 Dec 2025 0 Mar 2026 -0.13 Jun 2026 0 - Profit
- ₹ crore
Jun 20260.08
Quarter ₹ crore YoY Jun 2024 -0.72 -111.4% Sept 2024 3 +5.4% Dec 2024 0.95 +132.2%* Mar 2025 1 -9.9% Jun 2025 3 +568.3%* Sept 2025 3 +19.4% Dec 2025 2 +93.8% Mar 2026 3 +109.7% Jun 2026 0.08 -97.8% - Per share
- ₹ per share
Jun 20260.03
Quarter ₹ per share Jun 2024 -0.31 Sept 2024 1.11 Dec 2024 0.40 Mar 2025 0.55 Jun 2025 1.43 Sept 2025 1.32 Dec 2025 0.78 Mar 2026 1.16 Jun 2026 0.03
| ₹ crore | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 33 | 40 | 33 | 39 | 35 | 35 | 38 | 42 | 27 | |
| Revenue YoY | -20.6% | -0.9% | +16.7% | -5.6% | +4.0% | -12.0% | +15.4% | +8.1% | -23.2% |
| 0.51 | 1 | 0.19 | 1 | 0.60 | 1 | 1 | 2 | 2 | |
| 34 | 41 | 33 | 40 | 35 | 37 | 40 | 44 | 28 | |
| Cost structure | |||||||||
| 5 | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 6 | |
| 34 | 39 | 32 | 37 | 32 | 34 | 38 | 41 | 28 | |
| Exceptional items and tax | |||||||||
| -0.72 | 3 | 0.95 | 1 | 3 | 3 | 2 | 3 | 0.08 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.13 | 0 | |
| Profit | |||||||||
| -0.72 | 3 | 0.95 | 1 | 3 | 3 | 2 | 3 | 0.08 | |
| Net profit YoY | -111.4% | +5.4% | +132.2%* | -9.9% | +568.3%* | +19.4% | +93.8% | +109.7% | -97.8% |
| Per share | |||||||||
| -0.31 | 1.11 | 0.40 | 0.55 | 1.43 | 1.32 | 0.78 | 1.16 | 0.03 | |
Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.